-
Signature
-
/s/ Stephen Feider
-
Issuer symbol
-
BBNX
-
Transactions as of
-
01 Oct 2025
-
Net transactions value
-
-$235,214
-
Form type
-
4
-
Filing time
-
03 Oct 2025, 16:31:50 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Feider Stephen |
Chief Financial Officer |
C/O BETA BIONICS, INC., 11 HUGHES, IRVINE |
/s/ Stephen Feider |
02 Oct 2025 |
0002048588 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BBNX |
Common Stock |
Options Exercise |
$76,592 |
+15,018 |
+34% |
$5.10 |
59,059 |
01 Oct 2025 |
Direct |
|
| transaction |
BBNX |
Common Stock |
Sale |
$309,698 |
-14,918 |
-25% |
$20.76 |
44,141 |
01 Oct 2025 |
Direct |
F1, F2 |
| transaction |
BBNX |
Common Stock |
Sale |
$2,108 |
-100 |
-0.23% |
$21.08 |
44,041 |
01 Oct 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BBNX |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-15,018 |
-17% |
$0.000000 |
74,677 |
01 Oct 2025 |
Common Stock |
15,018 |
$5.10 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: